All In Biotech

Drug Trial Radar · NCT03144674

A Study of INCB050465 in Subjects With Relapsed or Refractory Marginal Zone Lymphoma (CITADEL-204)

A Phase 2, Open-Label, 2-Cohort Study of INCB050465, a PI3Kδ Inhibitor, in Subjects With Relapsed or Refractory Marginal Zone Lymphoma With or Without Prior Exposure to a BTK Inhibitor (CITADEL-204)

Last checked: Nov 19, 2026Latest source record: Jul 11, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

110

Actual

Start

Dec 18, 2017

Primary completion

Jan 15, 2021

Study completion May 29, 2024

Sponsor

Lead sponsor
Incyte CorporationIncyte (INCY)
Sponsor type
Industry
First posted
May 9, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety and efficacy of two parsaclisib treatment regimens in participants diagnosed with relapsed or refractory marginal zone lymphoma (MZL) who are naive to or were previously treated with a Bruton's tyrosine kinase (BTK) inhibitor.

Conditions

  • Lymphoma

Interventions

  • ParsaclisibDrug

    Parsaclisib at the protocol-defined dose.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Objective Response Rate (ORR) Based on Lugano Classification CriteriaTime frame: Up to approximately 161 weeks

Locations

86 sites in 12 countries. Site status is shown where the registry gives one.

  • University of Alabama At Birmingham Comprehensive Cancer Center

    Birmingham, Alabama

  • Arizona Oncology Associates

    Tempe, Arizona

  • Torrance Health Association

    Redondo Beach, California

  • Sansum Clinic

    Santa Barbara, California

  • Central Coast Medical Oncology

    Santa Maria, California

  • UCLA Healthcare Hematology-Oncology

    Santa Monica, California

  • St. Joseph Heritage Healthcare

    Santa Rosa, California

  • Innovative Clinical Research Institute

    Whittier, California

  • Loyola University Medical Center

    Whittier, California

  • Valley View Hospital

    Glenwood Springs, Colorado

  • St. Mary'S Hospital Regional Cancer Center

    Grand Junction, Colorado

  • University of Miami Sylvester Comprehensive Cancer Center

    Miami, Florida

  • Advanced Pharma Cr

    Miami, Florida

  • Boca Raton Clinical Research Medical Inc.

    Plantation, Florida

  • Asclepes Research Centers

    Weeki Wachee, Florida

  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University

    Chicago, Illinois

  • Rush University Medical Center - Consultants in Hematology

    Chicago, Illinois

  • Clinical Trials of Swla Llc

    Lake Charles, Louisiana

  • University of Michigan Cancer Center

    Ann Arbor, Michigan

  • Henry Ford Health System

    Detroit, Michigan

  • Saint Luke'S Hospital of Kansas City

    Kansas City, Missouri

  • COMPREHENSIVE CANCER CeNTERS OF NEVADA - TWAIN

    Las Vegas, Nevada

  • Clinical Research Alliance

    New Hyde Park, New York

  • Nyu Cancer Institute

    New York, New York

  • Hematology Oncology Associates of Rockland

    Nyack, New York

  • White Plains Hospital

    White Plains, New York

  • Duke University Medical Center

    Durham, North Carolina

  • Gabrail Cancer Center

    Canton, Ohio

  • Gettysburg Cancer Center

    Gettysburg, Pennsylvania

  • Charleston Hematology Oncology Associates Pa

    Charleston, South Carolina

  • Renovatio Clinical

    The Woodlands, Texas

  • University of Washington - Seattle Cancer Care Alliance

    Seattle, Washington

  • Medical College of Wisconsin

    Milwaukee, Wisconsin

  • Aou Maggiore Della Carita

    Rosario, Argentina

  • Icon Cancer Care

    Auchenflower, Queensland, Australia

  • Royal Adelaide Hospital

    Adelaide, South Australia, Australia

  • Calvary North Adelaide Hospital

    North Adelaide, South Australia, Australia

  • Cliniques Universitaires Ucl Saint-Luc

    Brussels, Belgium

  • Universitair Ziekenhuis Gent

    Ghent, Belgium

  • Universitaire Ziekenhuis Leuven - Gasthuisberg

    Leuven, Belgium

Showing 40 of 86 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.